These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27329026)

  • 1. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2).
    Louraki M; Katsalouli M; Kanaka-Gantenbein C; Kafassi N; Critselis E; Kallinikou D; Tsentidis C; Karavanaki K
    Diabetes Res Clin Pract; 2016 Jul; 117():82-90. PubMed ID: 27329026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
    Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
    Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
    Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
    J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes.
    Kawasaki E; Kuriya G; Satoh T; Fujishima K; Moriuchi A; Fukushima K; Ozaki M; Abiru N; Yamasaki H; Eguchi K
    Ann N Y Acad Sci; 2008 Dec; 1150():248-51. PubMed ID: 19120305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in prevalence of antibodies to GAD and IA-2 and their titers at diagnosis in children with slowly and rapidly progressive forms of type 1 diabetes.
    Urakami T; Yoshida A; Suzuki J; Saito H; Wada M; Takahashi S; Mugishima H
    Diabetes Res Clin Pract; 2009 Jan; 83(1):89-93. PubMed ID: 19019475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.
    Ota T; Takamura T; Nagai Y; Bando Y; Usuda R
    Diabetes Res Clin Pract; 2005 Jan; 67(1):63-9. PubMed ID: 15620435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
    Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
    Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet autoantibodies present in association with Ljungan virus infection in bank voles (Myodes glareolus) in northern Sweden.
    Warvsten A; Björnfors M; Arvidsson M; Vaziri-Sani F; Jönsson I; Olsson GE; Ahlm C; Larsson HE; Lernmark Å; Nilsson AL
    J Med Virol; 2017 Jan; 89(1):24-31. PubMed ID: 27283793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children.
    Wahlberg J; Fredriksson J; Nikolic E; Vaarala O; Ludvigsson J;
    Pediatr Diabetes; 2005 Dec; 6(4):199-205. PubMed ID: 16390388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
    Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
    Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk.
    Hämäläinen AM; Ronkainen MS; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4249-53. PubMed ID: 11095462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
    Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
    Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia.
    Bonifacio E; Yu L; Williams AK; Eisenbarth GS; Bingley PJ; Marcovina SM; Adler K; Ziegler AG; Mueller PW; Schatz DA; Krischer JP; Steffes MW; Akolkar B
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3360-7. PubMed ID: 20444913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
    Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers.
    Lindehammer SR; Hansson I; Midberg B; Ivarsson SA; Lynch KF; Dillner J; Lernmark A;
    J Reprod Immunol; 2011 Jan; 88(1):72-9. PubMed ID: 21111487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.